Phynova has signed a global distribution and collaboration agreement for its Reducose ingredient with DSM.
Photo © stock.adobe,com/6okean
Phynova (Oxfordshire, UK) has signed a global distribution and collaboration agreement for its Reducose ingredient with DSM (Kaiseraugst, Switzerland). Reducose is a patented water extract of white mulberry leaves (Morus alba) that supports healthy blood glucose levels by reducing the absorption of sugars and other carbohydrate by up to 40%, says the company.
“We are delighted to work with DSM, the leading global health and nutrition ingredient specialist,” said Robert Miller, CEO of Phynova, in a press release. “Along with the distribution and sales of Reducose, we will collaborate closely with them on product development, clinical research, regulatory approvals, and marketing.”
“Phynova is a strategic partner for DSM to provide the right nutritional solutions to address the ever-growing health concerns linked to maintaining healthy blood glucose,” explained Ivo Lansbergen, VP global strategic marketing, DSM Human Nutrition and Health, in a press release. “The combined strengths of DSM and Phynova provide an excellent platform for addressing this major societal challenge.”
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.